Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GATSBY: T-DM1 vs Taxane in Advanced Gastric Cancer
NCT01641939Phase 3Terminated
- Sponsor
- Roche
- Start
- Sep 2012
- Primary completion
- Jun 2015
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of trastuzumab emtansine in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Roche. Started Sep 2012; status: terminated.
02
Drugs
trastuzumab emtansine
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01641939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01641939.